Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi: Bone Marrow Transplantation

M. Merli, S. Luminari, L. Farina, F. Cocito, I. Defrancesco, G. Gini, A. Arcari, G. Scapinello, M. Gentile, M. Goldaniga, G. Loseto, E. Cencini, A. Greco, A.L. Molinari, A. Ferrario, B. Bianchi, B. Mora, L. Bertù, V. Saturni, F. BergaminiN. Fabbri, F.G. Rossi, S. Bolis, F. Passamonti, L. Arcaini

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2350-2353
Number of pages4
JournalBone Marrow Transplant.
Volume55
Issue number12
DOIs
Publication statusPublished - 2020

Keywords

  • bendamustine
  • CD34 antigen
  • cytarabine
  • fludarabine
  • granulocyte colony stimulating factor
  • ibritumomab tiuxetan
  • platinum complex
  • plerixafor
  • rituximab
  • autologous stem cell transplantation
  • bone marrow
  • cancer immunotherapy
  • cell count
  • drug megadose
  • engraftment
  • follicular lymphoma
  • human
  • indolent nonhodgkin lymphoma
  • Italy
  • Letter
  • marginal zone lymphoma
  • nonhodgkin lymphoma
  • overall survival
  • peripheral blood stem cell
  • pneumonia
  • priority journal
  • relapse
  • sepsis
  • stem cell mobilization
  • Waldenstroem macroglobulinemia

Cite this